BARBIERI, Elena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.019
EU - Europa 2.115
AS - Asia 1.479
SA - Sud America 238
AF - Africa 37
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 3
Totale 7.901
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.987
GB - Regno Unito 485
CN - Cina 470
IT - Italia 467
SG - Singapore 454
IE - Irlanda 346
HK - Hong Kong 229
SE - Svezia 216
DE - Germania 204
BR - Brasile 193
VN - Vietnam 110
UA - Ucraina 105
RU - Federazione Russa 91
FI - Finlandia 61
TR - Turchia 45
BG - Bulgaria 35
IN - India 31
FR - Francia 29
ID - Indonesia 29
KR - Corea 19
IR - Iran 18
CA - Canada 17
AR - Argentina 15
ZA - Sudafrica 15
NL - Olanda 13
PL - Polonia 13
IQ - Iraq 12
JP - Giappone 9
MX - Messico 9
AU - Australia 8
BD - Bangladesh 8
EC - Ecuador 7
ES - Italia 6
NG - Nigeria 6
PK - Pakistan 6
VE - Venezuela 6
AT - Austria 5
BE - Belgio 5
EG - Egitto 5
LT - Lituania 5
MT - Malta 5
MY - Malesia 5
PY - Paraguay 5
TW - Taiwan 5
AZ - Azerbaigian 4
CL - Cile 4
CO - Colombia 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
EU - Europa 3
JO - Giordania 3
NP - Nepal 3
UZ - Uzbekistan 3
BO - Bolivia 2
CH - Svizzera 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
HN - Honduras 2
IL - Israele 2
LB - Libano 2
NZ - Nuova Zelanda 2
PA - Panama 2
PH - Filippine 2
PT - Portogallo 2
RO - Romania 2
SA - Arabia Saudita 2
SI - Slovenia 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
CI - Costa d'Avorio 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
HU - Ungheria 1
KE - Kenya 1
KG - Kirghizistan 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MK - Macedonia 1
MN - Mongolia 1
MU - Mauritius 1
NO - Norvegia 1
OM - Oman 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TJ - Tagikistan 1
TN - Tunisia 1
Totale 7.901
Salva come PNG Salva come JPEG
Città #
Santa Clara 420
Dublin 346
Ashburn 329
Fairfield 322
Singapore 312
Southend 298
Chandler 265
Hong Kong 227
Woodbridge 224
Houston 183
Jacksonville 175
Dearborn 168
Ann Arbor 162
Nyköping 131
Chicago 122
Wilmington 120
Beijing 119
Seattle 118
Cambridge 107
Los Angeles 95
London 84
Hefei 82
New York 61
Modena 56
Dallas 44
Munich 43
The Dalles 38
Princeton 37
Moscow 36
Sofia 35
Ho Chi Minh City 33
Salt Lake City 33
Eugene 32
Helsinki 31
Izmir 30
Shanghai 29
Tampa 26
Elk Grove Village 25
Jakarta 25
San Diego 25
Bremen 24
Council Bluffs 22
Dong Ket 22
Rome 22
São Paulo 22
Hanoi 21
Bologna 20
Seoul 19
Milan 18
Columbus 17
Buffalo 16
Fremont 16
Sterling 15
Lancaster 14
Redwood City 14
San Jose 11
Catania 10
Orem 10
Phoenix 10
Turku 10
Atlanta 9
Norwalk 9
Redondo Beach 9
Poplar 8
Denver 7
Des Moines 7
Falls Church 7
Frankfurt am Main 7
Palermo 7
San Mateo 7
Warsaw 7
Amsterdam 6
Brasília 6
Brooklyn 6
Dulles 6
Ferrara 6
Florence 6
Nanjing 6
Padova 6
Pittsburgh 6
Stockholm 6
Tokyo 6
Belo Horizonte 5
Cape Town 5
Chengdu 5
Detroit 5
Haiphong 5
Lagos 5
Monmouth Junction 5
Montreal 5
Newark 5
Pisa 5
Reggio Emilia 5
Rio de Janeiro 5
Wuhan 5
Bari 4
Boardman 4
Brescia 4
Brussels 4
Curitiba 4
Totale 5.616
Salva come PNG Salva come JPEG
Nome #
ShortHER: TRATTAMENTO ADIUVANTE CON HERCEPTIN PER 3 MESI VERSO 12 MESI, IN ASSOCIAZIONE CON DUE DIFFERENTI REGIMI DI CHEMIOTERAPIA, NELLE PAZIENTI CON CARCINOMA MAMMARIO HER2 POSITIVO 438
Magnetic Resonance Imaging and Ultrasonography in Predicting Infiltrating Residual Disease after Preoperative Chemotherapy in Stage II-III Breast Cancer 393
Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management 373
Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis. 353
Use of Recombinant Factor IX and Thromboelastography in a Patient With Hemophilia B Undergoing Liver Transplantation: A Case Report 351
Posterior reversible encephalopathy syndrome during ipilimumab therapy for malignant melanoma 318
Achievements and unmet needs in the management of advanced ovarian cancer 291
Predictive and prognostic role of p53 according to tumor phenotype in breast cancer patients treated with preoperative chemotherapy: a single-institution analysis 286
Primary pulmonary cancer colliding with metastatic breast carcinoma: hitherto unreported cases of cancer-to-cancer metastasis focusing on clinical implications 277
Primary and secondary prevention to effectively reduce the risk of bisphosphonate-related osteonecrosis of the jaw in patients with bone metastases . 265
Anti-HER2 neoadjuvant and adjuvant therapies in HER2 positive breast cancer 260
Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single Institution analysis 257
Double-blind, placebo-controlled, multicentric randomized phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal HER2-negative, hormone receptor-positive operable breast cancer 256
Ki67 as a Predictor of Response and Long Term Survival in Hormone Receptor Positive/HER2 Negative Breast Cancer Patients Treated with Preoperative Chemotherapy 237
Clinical-Pathological Characteristics of HER2+ Breast Cancers patients among BRCA1/2+ carriers tested in Modena Cancer Center. 230
PREVALENCE OF NODE NEGATIVE AND SMALL SIZE TUMORS IN A NATIONAL, RANDOMISED, PHASE III ADJUVANT TRIAL IN HER2 + EARLY BREAST CANCER (SHORT-HER STUDY) 227
Timing for starting second-line therapy in recurrent ovarian cancer 227
Biomarkers predicting clinical benefit: fact or fiction? 216
Prognostic impact of estrogen receptor (ER) level changes during progression for patients with both ER-positive (ER+) primary breast cancer and paired recurrence 214
Change in HER2 Status in HER2 Positive Operable Breast Cancer Patients Treated with Neoadjuvant Chemotherapy with or without Anti-HER2 Therapy: Analysis of Two Consecutive Cohorts 208
COMPARISON OF HER-2 STATUS IN PRIMARY BREAST CANCER AND METASTATIC SITES: RESULTS FROM A SINGLE INSTITUTION ANALYSIS 197
Discordant HER2 Total and HER2 Homodimer Levels by HERmark Analysis in Matched Primary and Metastatic Breast Cancer FFPE Specimens. 197
Tumori ginecologici 192
35. PREDICTORS OF HER2 FISH POSITIVITY IN PRIMARY BREAST CANCER DIAGNOSIS SCORED 2+ WITH IHC: RESULTS OF A SINGLE INSTITUTION ANALYSIS 191
P53 EXPRESSION IS A SIGNIFICANT PREDICTOR OF RESPONSE AND PROGNOSIS IN STAGE II-III BREAST CANCER PATIENTS TREATED WITH PREOPERATIVE CHEMOTHERAPY 189
ShortHER: TRATTAMENTO ADIUVANTE CON HERCEPTIN PER 3 MESI VERSO 12 MESI, IN ASSOCIAZIONE CON DUE DIFFERENTI REGIMI DI CHEMIOTERAPIA, NELLE PAZIENTI CON CARCINOMA MAMMARIO HER2 POSITIVE: ANALISI PRELIMINARE DELLE TOSSICITA’ 188
Automated capture-based NGS workflow: one thousand patients experience in a clinical routine framework 170
Prognostic role of HER2 loss after neoadjuvant therapy in patients with HER2-positive operable breast cancer 168
ACHIEVEMENTS AND UNMET NEEDS IN THE MANAGEMENT OF EPITHELIAL OVARIAN CANCER 167
KI67 AS A PREDICTOR OF RESPONSE AND LONG TERM SURVIVAL IN HORMONE RECEPTOR POSITIVE/HER2 NEGATIVE BREAST CANCER PATIENTS TREATED WITH PREOPERATIVE CHEMOTHERAPY 157
VALUTAZIONE DEL RISCHIO DI TOSSICITA’ CARDIACA DI TRASTUZUMAB IN PAZIENTI AFFETTE DA CARCINOMA MAMMARIO IN TRATTAMENTO ADIUVANTE 132
Quantitative HER2 measurement and PI3K mutation profile in matched primary and metastatic breast cancer tissues. 130
Adjuvant Endocrine Therapy in Premenopausal Women With Hormone Receptor-Positive Early-Stage Breast Cancer: Risk Stratification in a Real-World Setting 129
PREDICTIVE AND PROGNOSTIC ROLE OF P53 EXPRESSION IN STAGE II-III BREAST CANCER PATIENTS TREATED WITH PREOPERATIVE CHEMOTHERAPY: A SINGLE INSTITUTION ANALYSIS 83
Totale 7.967
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.654
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.654
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021374 0 0 0 0 0 58 52 72 45 54 57 36
2021/2022539 9 86 57 12 11 23 27 13 64 45 121 71
2022/20231.047 97 98 58 76 71 103 13 62 403 11 29 26
2023/2024559 24 21 40 39 71 46 49 118 21 27 44 59
2024/20251.508 17 41 35 110 308 251 86 104 161 69 132 194
2025/20261.748 186 68 206 407 689 192 0 0 0 0 0 0
Totale 7.967